Verastem Oncology
Company Profile
At Verastem Oncology, we’re advancing innovation and addressing the urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. The FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy specifically for women living with recurrent KRAS‑mutated low‑grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve successfully launched this innovative combination therapy in the U.S. and are exploring regulatory pathways for Europe and Japan.
We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients.
Key Responsibilities
Drive global study start-up and site activation activities, milestone oversight, and CRO delivery.
Support new vendor and CRO identification, evaluation, and selection, including RFP processes, bid defenses, and selection.
Support vendor and CRO contract negotiations and downstream changes in scope.
Develop and deliver the global study startup plan by partnering with the CRO Study Startup team.
Participate in early, global, strategic study planning to ensure corporate goals and timelines for study start‑up and site activation are accurate and achievable; ensure CRO commitment to all study deliverables, timelines, and performance objectives.
Lead development of procedures and tools to enhance internal start‑up capabilities and drive efficiencies, including site contract and budget templates.
Guide study teams through conduct and delivery of key startup activities within timelines that contribute to operational planning/decisions resulting in predictable delivery for achieving goals.
Oversee the analysis of clinical trial data and its application to conduct accurate study startup forecasts.
Collaborate with internal stakeholders to drive rapid, accurate, and data‑driven study startup forecasts, benchmarking assumptions, scenarios, and accurate operational planning.
Develop creative processes, methodologies, data and technologies to ensure ongoing delivery of efficient study startup services.
Partner with CRO to ensure efficient start‑up processes and transparent reporting to deliver best in practice country and site activations.
Work directly with internal study team members and CRO counterparts to progress site activations efficiently and as per targeted milestones; facilitates timely resolution of site‑level issues.
Tracks and reports relevant KPIs and metrics including local country and site level cycle times to support process improvement and overall operational/business reporting to accelerate site activation.
Oversee consistent application of appropriate study start‑up standards and processes to deliver high quality, cost effective clinical studies in line with local operational, legal and regulatory requirements.
Build and maintain study start‑up, country and site activation best practices.
Support the recruitment and performance of junior staff; provide guidance for effective prioritization, problem identification and solving resulting in improved strategic drug development operational efficiency.
Oversee dedicated TMF Document Specialist in the overall set‑up and maintenance of the Trial Master File across trials.
Oversee dedicated staff responsible for site budget and contract negotiations.
Qualifications
Bachelor’s Degree in Science or related discipline.
Significant (8+ years) previous experience gained with a CRO or biopharmaceutical company working on multinational clinical studies, preferably in oncology.
Broad‑based experience in clinical development including clinical trial conduct, Study Start-up and feasibility, country and site selection and patient retention and recruitment.
Strong knowledge of GCP and a solid understanding of the processes associated with clinical operations, study management and monitoring, and local regulatory requirements.
Significant experience in leading global study start‑up and site activation activities is required.
Strong knowledge of EU CTIS regulatory processes and timelines.
Must have prior experience:
Working for or with CROs and cross‑functional teams
Writing RFPs and managing CRO selection process
Reviewing, assessing, and managing CRO and other vendor/service provider SOWs and budgets
Reviewing, assessing, and negotiating site budgets and contracts
The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job‑related skills, experience, internal equity, relevant education or training, location, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package.
#J-18808-Ljbffr
We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients.
Key Responsibilities
Drive global study start-up and site activation activities, milestone oversight, and CRO delivery.
Support new vendor and CRO identification, evaluation, and selection, including RFP processes, bid defenses, and selection.
Support vendor and CRO contract negotiations and downstream changes in scope.
Develop and deliver the global study startup plan by partnering with the CRO Study Startup team.
Participate in early, global, strategic study planning to ensure corporate goals and timelines for study start‑up and site activation are accurate and achievable; ensure CRO commitment to all study deliverables, timelines, and performance objectives.
Lead development of procedures and tools to enhance internal start‑up capabilities and drive efficiencies, including site contract and budget templates.
Guide study teams through conduct and delivery of key startup activities within timelines that contribute to operational planning/decisions resulting in predictable delivery for achieving goals.
Oversee the analysis of clinical trial data and its application to conduct accurate study startup forecasts.
Collaborate with internal stakeholders to drive rapid, accurate, and data‑driven study startup forecasts, benchmarking assumptions, scenarios, and accurate operational planning.
Develop creative processes, methodologies, data and technologies to ensure ongoing delivery of efficient study startup services.
Partner with CRO to ensure efficient start‑up processes and transparent reporting to deliver best in practice country and site activations.
Work directly with internal study team members and CRO counterparts to progress site activations efficiently and as per targeted milestones; facilitates timely resolution of site‑level issues.
Tracks and reports relevant KPIs and metrics including local country and site level cycle times to support process improvement and overall operational/business reporting to accelerate site activation.
Oversee consistent application of appropriate study start‑up standards and processes to deliver high quality, cost effective clinical studies in line with local operational, legal and regulatory requirements.
Build and maintain study start‑up, country and site activation best practices.
Support the recruitment and performance of junior staff; provide guidance for effective prioritization, problem identification and solving resulting in improved strategic drug development operational efficiency.
Oversee dedicated TMF Document Specialist in the overall set‑up and maintenance of the Trial Master File across trials.
Oversee dedicated staff responsible for site budget and contract negotiations.
Qualifications
Bachelor’s Degree in Science or related discipline.
Significant (8+ years) previous experience gained with a CRO or biopharmaceutical company working on multinational clinical studies, preferably in oncology.
Broad‑based experience in clinical development including clinical trial conduct, Study Start-up and feasibility, country and site selection and patient retention and recruitment.
Strong knowledge of GCP and a solid understanding of the processes associated with clinical operations, study management and monitoring, and local regulatory requirements.
Significant experience in leading global study start‑up and site activation activities is required.
Strong knowledge of EU CTIS regulatory processes and timelines.
Must have prior experience:
Working for or with CROs and cross‑functional teams
Writing RFPs and managing CRO selection process
Reviewing, assessing, and managing CRO and other vendor/service provider SOWs and budgets
Reviewing, assessing, and negotiating site budgets and contracts
The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job‑related skills, experience, internal equity, relevant education or training, location, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package.
#J-18808-Ljbffr